nach oben

Erschienen in:

27.01.2020 | Review

Repetitive Magnetic Stimulation for the Management of Peripheral Neuropathic Pain: A Systematic Review

verfasst von: Abdullah Aamir, Ayesha Girach, Ptolemaios Georgios Sarrigiannis, Marios Hadjivassiliou, Antonela Paladini, Giustino Varrassi, Panagiotis Zis

Erschienen in: Advances in Therapy | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Repetitive magnetic stimulation (rMS) is a safe and well-tolerated intervention. Transcranial magnetic stimulation (TMS) is used for the treatment of depression and for the treatment and prevention of migraine. Over the last few years, several reports and randomised controlled studies of the use of rMS for the treatment of pain have been published. The aim of this systematic review was to identify the available literature regarding the use of rMS in the treatment of peripheral neuropathic pain.

Methods

After a systematic Medline search we identified 12 papers eligible to be included in this review.

Results

The majority of the studies were on patients with phantom limb pain, followed by radiculopathy, plexopathy, post-traumatic pain and peripheral neuropathy. The treatment protocols vary significantly from study to study and, therefore, pooling the results together is currently difficult. However, rMS has a definite immediate effect in pain relief which, in the majority of studies, is maintained for a few weeks.

Conclusion

rMS seems to be a promising intervention in the treatment of peripheral neuropathic pain. Further research is in the field is needed. Use of neuronavigation might increase the precision of stimulation and subsequently its effectiveness.

Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008–39.PubMedPubMedCentralCrossRef

Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;325(8437):1106–7.CrossRef

Eldaief MC, Press DZ, Pascual-Leone A. Transcranial magnetic stimulation in neurology. A review of established and prospective applications. Neurol Clin Pract. 2013;3(6):519–26.PubMedPubMedCentralCrossRef

Aleman A. Use of repetitive transcranial magnetic stimulation for treatment in psychiatry. Clin Psychopharmacol Neurosci. 2013;11(2):53–9.PubMedPubMedCentralCrossRef

Zis P, Shafique F, Hadjivassiliou M, et al. Safety, tolerability, and nocebo phenomena during transcranial magnetic stimulation: a systematic review and meta-analysis of placebo-controlled clinical trials. Neuromodul Technol Neural Interface. 2019. https://doi.org/10.1111/ner.12946.

Girach A, Julian TH, Varrassi G, Paladini A, Vadalouka A, Zis P. Quality of life in painful peripheral neuropathies: a systematic review. Pain Res Manag. 2019;2019:2091960.CrossRef

Zis P, Sarrigiannis PG, Rao DG, Sanders DS, Hadjivassiliou M. Small fiber neuropathy in coeliac disease and gluten sensitivity. Postgrad Med. 2019;131(7):496–500.PubMedCrossRef

Michaelides A, Hadden RDM, Sarrigiannis PG, Hadjivassiliou M, Zis P. Pain in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Pain Ther. 2019;8(2):177–85.PubMedPubMedCentralCrossRef

Zis P, Sarrigiannis PG, Rao DG, Hewamadduma C, Hadjivassiliou M. Chronic idiopathic axonal polyneuropathy: prevalence of pain and impact on quality of life. Brain Behav. 2019;9(1):e01171.PubMedCrossRef

10.

Zis P, Sarrigiannis PG, Rao DG, Hadjivassiliou M. Gluten neuropathy: prevalence of neuropathic pain and the role of gluten-free diet. J Neurol. 2018;265(10):2231–6.PubMedCrossRef

11.

Zis P, Sarrigiannis P, Rao D, Hadjivassiliou M. Quality of life in patients with gluten neuropathy: a case-controlled study. Nutrients. 2018;10(6):662.PubMedCentralCrossRef

12.

Brozou V, Vadalouca A, Zis P. Pain in platin-induced neuropathies: a systematic review and meta-analysis. Pain Ther. 2018;7(1):105–19.PubMedCrossRef

13.

Zis P, Paladini A, Piroli A, McHugh PC, Varrassi G, Hadjivassiliou M. Pain as a first manifestation of paraneoplastic neuropathies: a systematic review and meta-analysis. Pain Ther. 2017;6(2):143–51.PubMedPubMedCentralCrossRef

14.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.PubMedCrossRef

15.

Di Rollo A, Pallanti S. Phantom limb pain: low frequency repetitive transcranial magnetic stimulation in unaffected hemisphere. Case Rep Med. 2011;2011:130751.

16.

Malavera A, Silva FA, Fregni F, Carrillo S, Garcia RG. Repetitive transcranial magnetic stimulation for phantom limb pain in land mine victims: a double-blinded, randomized, sham-controlled trial. J Pain. 2016;17(8):911–8.PubMedPubMedCentralCrossRef

17.

Bókkon I, Till A, Grass F, Erdöfi Szabó A. Phantom pain reduction by low-frequency and low-intensity electromagnetic fields. Electromagn Biol Med. 2011;30(3):115–27.PubMedCrossRef

18.

Nardone R, Versace V, Sebastianelli L, et al. Transcranial magnetic stimulation in subjects with phantom pain and non-painful phantom sensations: a systematic review. Brain Res Bull. 2019;148:1–9.PubMedCrossRef

19.

Dettmers C, Adler T, Rzanny R, et al. Increased excitability in the primary motor cortex and supplementary motor area in patients with phantom limb pain after upper limb amputation. Neurosci Lett. 2001;307(2):109–12.PubMedCrossRef

20.

Ahmed MA, Mohamed SA, Sayed D. Long-term antalgic effects of repetitive transcranial magnetic stimulation of motor cortex and serum beta-endorphin in patients with phantom pain. Neurol Res. 2011;33(9):953–8.PubMedCrossRef

21.

Scibilia A, Conti A, Raffa G, et al. Resting-state fMR evidence of network reorganization induced by navigated transcranial magnetic repetitive stimulation in phantom limb pain. Neurol Res. 2018;40(4):241–8.PubMedCrossRef

22.

Khedr EM, Abdel-Fadeil MR, Farghali A, Qaid M. Role of 1 and 3 Hz repetitive transcranial magnetic stimulation on motor function recovery after acute ischaemic stroke. Eur J Neurol. 2009;16(12):1323–30.PubMedCrossRef

23.

Lee J-H, Byun J-H, Choe Y-R, Lim S-K, Lee K-Y, Choi I-S. Successful treatment of phantom limb pain by 1 Hz repetitive transcranial magnetic stimulation over affected supplementary motor complex: a case report. Ann Rehabil Med. 2015;39(4):630–3.PubMedPubMedCentralCrossRef

24.

Diers M, Christmann C, Koeppe C, Ruf M, Flor H. Mirrored, imagined and executed movements differentially activate sensorimotor cortex in amputees with and without phantom limb pain. Pain. 2010;149(2):296–304.PubMedCrossRef

25.

Grammer GG, Williams-Joseph S, Cesar A, Adkinson DK, Spevak C. Significant reduction in phantom limb pain after low-frequency repetitive transcranial magnetic stimulation to the primary sensory cortex. Mil Med. 2015;180(1):e126–8.PubMedCrossRef

26.

Attal N, Ayache SS, De Andrade DC, et al. Repetitive transcranial magnetic stimulation and transcranial direct-current stimulation in neuropathic pain due to radiculopathy: a randomized sham-controlled comparative study. Pain. 2016;157(6):1224–31.PubMedCrossRef

27.

Töpper R, Foltys H, Meister IG, Sparing R, Boroojerdi B. Repetitive transcranial magnetic stimulation of the parietal cortex transiently ameliorates phantom limb pain-like syndrome. Clin Neurophysiol. 2003;114(8):1521–30.PubMedCrossRef

28.

Khedr EM, Ahmed MA, Alkady EAM, Mostafa MG, Said HG. Therapeutic effects of peripheral magnetic stimulation on traumatic brachial plexopathy: clinical and neurophysiological study. Neurophysiol Clin. 2012;42(3):111–8.PubMedCrossRef

29.

Loo CK, Taylor JL, Gandevia SC, McDarmont BN, Mitchell PB, Sachdev PS. Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some “sham” forms active? Biol Psychiatry. 2000;47(4):325–31.PubMedCrossRef

30.

Lefaucheur J-P, Drouot X, Ménard-Lefaucheur I, Nguyen J. Neuropathic pain controlled for more than a year by monthly sessions of repetitive transcranial magnetic stimulation of the motor cortex. Neurophysiol Clin Neurophysiol. 2004;34(2):91–5.CrossRef

31.

Leung A, Fallah A, Shukla S. Transcutaneous magnetic stimulation (tMS) in alleviating post-traumatic peripheral neuropathic pain states: a case series. Pain Med. 2014;15(7):1196–9.PubMedCrossRef

32.

Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.PubMedPubMedCentralCrossRef

33.

Onesti E, Gabriele M, Cambieri C, Ceccanti M, Raccah R, Di Stefano G, et al. H-coil repetitive transcranial magnetic stimulation for pain relief in patients with diabetic neuropathy. Eur J Pain. 2013;17(9):1347–56.PubMedCrossRef

34.

Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study. World J Biol Psychiatry. 2014;15(4):298–306.PubMedCrossRef

35.

Kranz G, Shamim EA, Lin PT, Kranz GS, Hallett M. Transcranial magnetic brain stimulation modulates blepharospasm: a randomized controlled study. Neurology. 2010;75(16):1465–71.PubMedPubMedCentralCrossRef

36.

Zangen A, Roth Y, Voller B, Hallett M. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol. 2005;116(4):775–9.PubMedCrossRef

37.

Apkarian AV, Bushnell MC, Treede R-D, Zubieta J-K. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9(4):463.PubMedCrossRef

38.

Lefaucheur J-P, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11):2150–206.PubMedCrossRef

39.

Siebner H, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res. 2003;148(1):1–16.PubMedCrossRef

40.

de Andrade DC, Mhalla A, Adam F, Texeira MJ, Bouhassira D. Neuropharmacological basis of rTMS-induced analgesia: the role of endogenous opioids. Pain. 2011;152(2):320–6.PubMedCrossRef

41.

Girach A, Aamir A, Zis P. The neurobiology under the placebo effect. Drugs Today. 2019;55(7):469.CrossRef

42.

DosSantos MF, Ferreira N, Toback RL, Carvalho AC, DaSilva AF. Potential mechanisms supporting the value of motor cortex stimulation to treat chronic pain syndromes. Front Neurosci. 2016;10:18.PubMedPubMedCentralCrossRef

43.

Bolognini N, Olgiati E, Maravita A, Ferraro F, Fregni F. Motor and parietal cortex stimulation for phantom limb pain and sensations. Pain. 2013;154(8):1274–80.PubMedCrossRef

44.

Lefaucheur JP, Drouot X, Ménard-Lefaucheur I, Keravel Y, Nguyen JP. Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain. Neurology. 2006;67(9):1568–74.PubMedCrossRef

45.

Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci. 2004;19(7):1950–62.PubMedCrossRef

46.

O’Connell NE, Marston L, Spencer S, DeSouza LH, Wand BM. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2018;4(4):CD008208.PubMed

Titel: Repetitive Magnetic Stimulation for the Management of Peripheral Neuropathic Pain: A Systematic Review
verfasst von: Abdullah Aamir
Ayesha Girach
Ptolemaios Georgios Sarrigiannis
Marios Hadjivassiliou
Antonela Paladini
Giustino Varrassi
Panagiotis Zis
Publikationsdatum: 27.01.2020
Verlag: Springer Healthcare
Erschienen in: Advances in Therapy / Ausgabe 3/2020
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI: https://doi.org/10.1007/s12325-020-01231-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis

Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan

A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release, Dulaglutide and Liraglutide in the UK

Letter to the Editor Regarding: Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Patients in Primary Care

An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK